Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.004 Å; R factor = 0.038; wR factor = 0.092; data-to-parameter ratio = 18.8.
The title compound, C 17 H 21 BrN 4 OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-HÁ Á ÁS hydrogen bond making a five-membered ring. In the crystal, molecules are connected into centrosymmetric dimers via pairs of N-HÁ Á ÁN and weak C-HÁ Á ÁN hydrogen bonds. The crystal structure also features C-HÁ Á ÁO interactions.
Related literature
The 1,2,4-triazole scaffold and its analogues are important pharmacophores that can be found in biologically active compounds across a number of different therapeutic areas, see: Lin et al. (2005) ; Naito et al. (1996) ; Sui et al. (1998) ; Tafi et al. (2002) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). The 1,2,4-triazole scaffold and its analogues are important pharmacophores that can be found in biologically active compounds across a number of different therapeutic areas; these include antifungal (Tafi, et al., 2002) , antibacterial (Sui, et al., 1998) , antiasthmatic (Naito, et al., 1996) and anticancer activities (Lin, et al., 2005) , etc. In the course of our search for new anti-HIV-1 agents, we have synthesized a new series of 1,2,4-triazole analogues, including the title compound, (I), as potential HIV-1 inhibitors.
The chemical structure of (I) is shown in Fig.1 . The molecule is stabilized by a weak intramolecular N4-H4···S1 hydrogen bond (Table 1 ). The cyclohexyl ring adopts the lowest energy chair conformation. The torsion angle (C1-N3 -C2-C3), which describes the arrangement between the cyclohexyl ring and the triazole moiety, is -112.1 (3) °; the torsion angle C12-N4-C11-O1, which characterizes the location of the CONH 2 group relative to the phenyl ring, is 3.5 (4) °. 
To a stirred solution of 2-((1H-1,2,4-triazol-3-yl)thio)-N-(4-bromophenyl)acetamide (3.12 g, 10 mmol) in anhydrous EtOH (75 ml) was added K 2 CO 3 (1.38 g, 0.01 mol) under a nitrogen atmosphere. The mixture was stirred at 298 K for 15 min, then (bromomethyl)cyclohexane (0.53 g, 0.03 mol) was added, and the reaction mixture was refluxed for 8 h under a nitrogen atmosphere. The reaction mixture was poured into cold H 2 O (80 ml), then the aqueous phase was extracted with EtOAc (3×50 ml). The combined organic layer was washed with H 2 O (3×50 ml), dried (Mg 2 SO 4 ), filtered and concentrated in vacuo to give the crude product, which was purified by chromatography (eluent EtOAc/PE 100:25) to afford the title compound (yield: 23%; m.p. 398.7-398.9 K). Single crystals of (I) suitable for X-ray diffraction were grown from a solution in EtOAc by slow evaporation. The product was characterized by IR, MS, 1 H NMR and 13 C NMR.
Refinement
All H atoms were placed in calculated positions with N-H = 0.86 Å and C-H = 0.93-0.98 Å, and with Uiso(H) = 1.2Ueq(C, N). SHELXTL (Sheldrick, 2008) .
Computing details

Figure 1
The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement ellipsoids. ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. Symmetry codes: (i) −x+1, −y+2, −z+1; (ii) x, y+1, z.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (
